["{\n\"step_by_step_thinking\": \"The documents provided are related to the use of transdermal glyceryl trinitrate (GTN) for various applications, including total parenteral nutrition, coronary thrombosis, and sublingual administration. However, none of these documents specifically mention prehospital stroke treatment or the RIGHT-2 trial. Therefore, based on the available information, it is not possible to determine the effectiveness of transdermal GTN for stroke in the RIGHT-2 trial.\",\n\"answer_choice\": \"B: no\"\n}"]